undamentalytics Newsletter
Sign in

Health Catalyst, Inc. cash flow statement

In fiscal 2025, Health Catalyst, Inc.'s operations generated $731,000 of cash; it spent $968,000 on capital projects, leaving free cash flow of −$237,000. It returned $5.0m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−37−40−32−26−23−35−3315128
Depreciation and amortisation67919384842415149
Stock-based pay441838657256402718
Capital spending22281021211
Free cash flow−39−42−34−34−34−37−3413−027
Free cash flow after stock pay−44−47−52−72−99−110−90−27−279
Share buybacks0900082050
Shares issued——195024500———

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: HCAT vs HSTMDH vs HCATAMWL vs HCAT

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Health Catalyst, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Health Catalyst, Inc.